Psycho-Oncologie is a specialized academic journal dedicated to the intersection of psychology and oncology, published by TECH SCIENCE PRESS. With an ISSN of 1778-3798 and E-ISSN of 1778-381X, this journal serves as an important platform for researchers and practitioners seeking to understand the psychological impact of cancer on patients and their families. Established in 2007 and converging with its findings through 2024, Psycho-Oncologie aims to disseminate high-quality research that enhances mental health and promotes effective treatment strategies within the oncological landscape. Although currently holding a Q4 ranking in disciplines such as Clinical Psychology and Oncology, the journal is committed to maintaining a high standard of research integrity and scientific rigor to foster future advancements. Although it operates under a non-open access model, the journal strives to make its valuable insights available to a broader audience. For those in the fields of psychology, oncology, and health care, Psycho-Oncologie is an essential resource for staying abreast of critical developments and contributing to interdisciplinary approaches in cancer treatment.

Revista de Psicoterapia is a prominent scholarly journal dedicated to the fields of psychotherapy and psychological practice, published by REVISTA PSIQUIATRIA & PSICOLOGIA HUMANISTA, S L. With its ISSN 1130-5142 and E-ISSN 2339-7950, the journal serves as a vital resource for researchers, practitioners, and students who seek to explore innovative therapeutic practices and advancements in the field of mental health. Although specific impact metrics like HIndex or Scopus rankings are currently unavailable, the journal is recognized for facilitating meaningful discourse on psychotherapy, showcasing empirical research, clinical studies, and theoretical advancements. It aims to promote evidence-based practices and interdisciplinary collaboration in the mental health community. As an essential platform in psychotherapy research, Revista de Psicoterapia fosters an understanding of psychological phenomena while addressing contemporary challenges in psychotherapy, making it indispensable for anyone committed to the advancement of psychological well-being.

VERHALTENSTHERAPIE, published by KARGER, is an authoritative journal in the field of Clinical Psychology and Psychiatry, with its ISSN being 1016-6262 and E-ISSN 1423-0402. This esteemed journal, based in Basel, Switzerland, has been disseminating valuable research insights since its inception in 1991, with a projected convergence up to 2024. Targeting healthcare professionals, researchers, and students, VERHALTENSTHERAPIE focuses on the latest advancements in behavioral therapy, offering a platform for the exchange of rigorous studies and innovative practices. The journal currently holds a Q3 ranking in Clinical Psychology and a Q4 ranking in Psychiatry and Mental Health for 2023, further asserting its role in informing clinical practice and research in these critical areas. Though it does not operate under an open access model, the journal ensures that high-quality research is made available, contributing significantly to both theoretical and practical aspects of mental health. By publishing cutting-edge research, case studies, and reviews, VERHALTENSTHERAPIE aims to foster knowledge and understanding that enriches the fields of psychology and psychiatry.

SCHMERZ is a pivotal journal in the fields of anesthesiology, pain medicine, and clinical neurology, published by SPRINGER HEIDELBERG in Germany. With an ISSN of 0932-433X and an E-ISSN of 1432-2129, the journal is celebrated for its rigorous peer-reviewed articles contributing to the understanding and management of pain. Since its inception in 1987, SCHMERZ has developed an impressive readership, ranking in the Q3 category across multiple disciplines, including Anesthesiology and Pain Medicine, and Clinical Neurology. Operating within the 50th percentile for anesthesiology and the 32nd percentile in neurology, the journal stands as a critical resource for practitioners, researchers, and students engaging with current trends and advancements in pain research and treatment. While not currently offering open access options, SCHMERZ continues to strive toward disseminating high-quality research and fostering vital discussions in the management of pain. With a scope that aims to bridge clinical practices with scientific understanding, SCHMERZ invites contributions that will illuminate and advance the multifaceted nature of pain and its treatment.

Iranian Journal of Psychiatry and Behavioral Sciences, published by BRIEFLAND, is a pivotal platform for scholars and practitioners in the fields of psychiatry and behavioral sciences. With its ISSN 1735-8639 and E-ISSN 1735-9287, this journal primarily caters to the Iranian context while fostering a global dialogue on contemporary issues in mental health, behavioral neurology, and biological psychiatry. Since its inception in 2007, the journal has committed to disseminating high-quality research and reviews, thereby contributing to its categorization in the fourth quartile (Q4) for both Behavioral Neuroscience and Biological Psychiatry as of 2023. Although currently lacking an open access model, the journal's accessibility to critical research discussions is vital for enhancing knowledge among researchers, professionals, and students alike. With emerging relevance in the Iranian mental health landscape, it aims to bridge gaps in understanding and promote evidence-based practices from 2007 to 2024 and beyond.

Deutsche Zeitschrift für Akupunktur is a distinguished journal published by Springer Heidelberg, focusing on the dynamic field of complementary and alternative medicine, with a particular emphasis on acupuncture practices and research. Established in 1984, the journal has been a platform for insightful articles that contribute to the understanding and advancement of acupuncture within the broader context of clinical neurology and medicine. Although its coverage in major databases like Scopus was discontinued in 2017, the journal retains relevance through its unique insights and the depth of its contributions during its operational years. As evidenced by its ranking in the lower quartiles of Scopus for its respective categories, the journal offers an opportunity for emerging scholars and seasoned professionals alike to engage with pioneering research and clinical applications. Importantly, while it does not offer open access, the journal serves as a vital resource for those dedicated to exploring the therapeutic potentials of acupuncture and enhancing patient care through alternative medicine approaches.

The Journal of Osteopathic Medicine, published by Walter de Gruyter GmbH, serves as a significant platform for advancing research and discourse within the realms of complementary and alternative medicine, as well as manual therapy. Since its inception in 2021, the journal has established a solid reputation with a commendable Q2 ranking in the respective categories for 2023, highlighting its impact and relevance in the field. The journal, based in Berlin, Germany, offers an Open Access model, ensuring that both emerging and established researchers have the opportunity to share their findings with a global audience, thereby fostering broader discussions and collaborations. With its commitment to publishing high-quality research, the Journal of Osteopathic Medicine aims to bridge the gap between scientific inquiry and practical application, ultimately enhancing the understanding and treatment approaches within osteopathy and related disciplines. Researchers, professionals, and students alike will find this journal an invaluable resource for staying updated with the latest advancements and methodologies in their field.

EATING DISORDERS, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing the understanding of eating disorders from diverse psychological, medical, and social perspectives. With an ISSN of 1064-0266 and an E-ISSN of 1532-530X, this journal is recognized for its rigorous peer-reviewed research and innovative studies, contributing significantly to the field of clinical psychology and psychiatry. It boasts impressive rankings, including a Q1 classification in Clinical Psychology and a Q1 classification in Medicine (miscellaneous) based on the 2023 category quartiles. Researchers will find its impactful insights invaluable, as it ranks 31st out of 311 in clinical psychology, placing it in the top 10% percentile. Although this journal is not open access, it encompasses a comprehensive range of topics related to eating disorders, fostering a deeper understanding that benefits practitioners, researchers, and students alike. For those dedicated to addressing the complexities of eating disorders, EATING DISORDERS is an essential resource that bridges the gap between research and real-world application.

Musculoskeletal Science and Practice is a premier academic journal published by Elsevier that focuses on the latest advancements in the field of physical therapy, sports therapy, and rehabilitation. With an ISSN of 2468-7812 and an impressive ranking in the Q1 category for 2023, this journal stands out among its peers, being positioned at #69 out of 247 in Scopus rankings within the Health Professions sector, demonstrating a significant impact factor that reflects its importance in the domain. As a dedicated Open Access platform, it aims to disseminate high-quality research and clinical practices to enhance rehabilitation outcomes for patients. The journal, established in the UK and converging its focus from 2017 to 2024, serves as an invaluable resource for professionals, researchers, and students, enabling them to stay informed about innovative practices and evidence-based strategies in musculoskeletal health. With the increasing demands for effective rehabilitation methods in today's healthcare landscape, Musculoskeletal Science and Practice plays a crucial role in shaping the future of therapeutic interventions and advancing the knowledge base in the field.

DEPRESSION AND ANXIETY is a leading academic journal published by WILEY, dedicated to presenting cutting-edge research in the fields of clinical psychology, psychiatry, and mental health. With an impressive impact factor underscoring its prominence—ranked in the top quartile (Q1) for both clinical psychology and psychiatry, and occupying the 7th and 20th ranks in Scopus respectively—this journal serves as a pivotal resource for researchers, professionals, and students alike. Since its inception in 1996 and continuing through 2024, DEPRESSION AND ANXIETY has been at the forefront of disseminating findings that significantly impact our understanding of mental health issues. The journal's rigorous peer-review process ensures the highest quality of published works, making it an essential platform for scholars aiming to advance knowledge and contribute meaningfully to the mental health discourse.